Sost Deficiency does not Alter Bone’s Lacunar or Vascular Porosity in Mice

SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone formation. In humans, mutations in the SOST gene lead to skeletal overgrowth and increased bone mineral density, suggesting that SCLEROSTIN is a key regulator of bone mass. The function of SCLEROSTIN as...

Full description

Bibliographic Details
Main Authors: Henry Mosey, Juan A. Núñez, Alice Goring, Claire E. Clarkin, Katherine A. Staines, Peter D. Lee, Andrew A. Pitsillides, Behzad Javaheri
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Materials
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmats.2017.00027/full